295 related articles for article (PubMed ID: 32069794)
1. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794
[TBL] [Abstract][Full Text] [Related]
2. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
[TBL] [Abstract][Full Text] [Related]
3. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet.
Reunala T; Salmi TT; Hervonen K
Acta Derm Venereol; 2015 Nov; 95(8):917-22. PubMed ID: 26059085
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo Culture of Duodenal Biopsies from Patients with Dermatitis Herpetiformis Indicates that Transglutaminase 3 Antibody Production Occurs in the Gut.
Hietikko M; Hervonen K; Ilus T; Salmi T; Huhtala H; Laurila K; Rauhavirta T; Reunala T; Kaukinen K; Lindfors K
Acta Derm Venereol; 2018 Mar; 98(3):366-372. PubMed ID: 29182792
[TBL] [Abstract][Full Text] [Related]
5. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
Hietikko M; Koskinen O; Kurppa K; Laurila K; Saavalainen P; Salmi T; Ilus T; Huhtala H; Kaukinen K; Lindfors K
BMC Immunol; 2018 Dec; 19(1):36. PubMed ID: 30522434
[TBL] [Abstract][Full Text] [Related]
6. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
[TBL] [Abstract][Full Text] [Related]
7. Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia.
Stamnaes J; Dorum S; Fleckenstein B; Aeschlimann D; Sollid LM
Amino Acids; 2010 Nov; 39(5):1183-91. PubMed ID: 20300788
[TBL] [Abstract][Full Text] [Related]
8. Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosis.
Salmi TT; Kurppa K; Hervonen K; Laurila K; Collin P; Huhtala H; Saavalainen P; Sievänen H; Reunala T; Kaukinen K
Dig Liver Dis; 2016 Jun; 48(6):632-7. PubMed ID: 27026081
[TBL] [Abstract][Full Text] [Related]
9. Dermatitis herpetiformis.
Kárpáti S
Clin Dermatol; 2012; 30(1):56-9. PubMed ID: 22137227
[TBL] [Abstract][Full Text] [Related]
10. T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis.
Caproni M; Capone M; Rossi MC; Santarlasci V; Maggi L; Mazzoni A; Rossettini B; Renzi D; Quintarelli L; Bianchi B; Ninci A; Lami G; Calabrò A; Cosmi L; Annunziato F; Liotta F
Front Immunol; 2021; 12():645143. PubMed ID: 33959126
[TBL] [Abstract][Full Text] [Related]
11. [Dermatitis herpetiformis].
Juratli HA; Görög A; Sárdy M
Hautarzt; 2019 Apr; 70(4):260-264. PubMed ID: 30868254
[TBL] [Abstract][Full Text] [Related]
12. Co-localization of IgA and TG3 on healthy skin of coeliac patients.
Cannistraci C; Lesnoni La Parola I; Cardinali G; Bolasco G; Aspite N; Stigliano V; Picardo M
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):509-14. PubMed ID: 17373979
[TBL] [Abstract][Full Text] [Related]
13. Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease.
Kaunisto H; Salmi T; Lindfors K; Kemppainen E
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328331
[TBL] [Abstract][Full Text] [Related]
14. TG6 Auto-Antibodies in Dermatitis Herpetiformis.
Hadjivassiliou M; Reunala T; Hervonen K; Aeschlimann P; Aeschlimann D
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32967363
[TBL] [Abstract][Full Text] [Related]
15. Dermatitis Herpetiformis: Novel Perspectives.
Antiga E; Maglie R; Quintarelli L; Verdelli A; Bonciani D; Bonciolini V; Caproni M
Front Immunol; 2019; 10():1290. PubMed ID: 31244841
[TBL] [Abstract][Full Text] [Related]
16. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis.
Hull CM; Liddle M; Hansen N; Meyer LJ; Schmidt L; Taylor T; Jaskowski TD; Hill HR; Zone JJ
Br J Dermatol; 2008 Jul; 159(1):120-4. PubMed ID: 18503599
[TBL] [Abstract][Full Text] [Related]
17. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
[TBL] [Abstract][Full Text] [Related]
18. Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis.
Kemppainen E; Salmi T; Lindfors K
Front Immunol; 2021; 12():657280. PubMed ID: 33854513
[TBL] [Abstract][Full Text] [Related]
19. Separate Gut Plasma Cell Populations Produce Auto-Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis.
Das S; Stamnaes J; Kemppainen E; Hervonen K; Lundin KEA; Parmar N; Jahnsen FL; Jahnsen J; Lindfors K; Salmi T; Iversen R; Sollid LM
Adv Sci (Weinh); 2023 Sep; 10(25):e2300401. PubMed ID: 37424036
[TBL] [Abstract][Full Text] [Related]
20. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
